PerkinElmer Collaborates with Helix to Drive Innovation in Personal Genomics
The personal genomics product will focus on 59 genes identified by the American College of Medical Genetics and Genomics
The personal genomics product will focus on 59 genes identified by the American College of Medical Genetics and Genomics
Discover how bit.bio's CRISPR-Ready ioCells eliminate months of cell line development
Hand-free library preparation to the G4 sequencing platform with the MagicPrep NGS system
The technology makes million-cell experiments routinely accessible for the first time
Scientists at KOTAI Biotechnologies share how they ensure nuclei and cell quality for reliable single-cell sequencing results
License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research
Enhanced’s 3D multi-omics platform delivers genetically validated targets for common diseases
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases
The panel covers entire genome of the new coronavirus to facilitate complete genome sequencing and support epidemiological studies
Learn how Bio-Rad has continually responded to researchers’ needs to drive innovation in its genomics technologies over the past 30 years
Grant received to use the Mission Bio Tapestri Platform to improve the measurement of residual cancerous cells remaining post-treatment
Mission Bio announces the potential for more impactful, dynamic therapy development and application for those with acute myeloid leukemia (AML)